Physician profile
Janet Lin
NPI 1356500524
$22,567.66
in general payments reported to CMS, 2019-2025
38 companies · $2,687 in 2025
The $2,687 reported for 2025 was more than what 82% of Dermatology providers received nationally (typical 2025 total: $772).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $7,895 · 2020: $890 · 2021: $1,612 · 2022: $2,810 · 2023: $4,451 · 2024: $2,222 · 2025: $2,687.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $8,819 · Education: $541.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $8,819.44 |
| Education | $540.71 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genzyme Corporation | $7,511.23 | 2019-2025 | |
| Abbvie INC. | $1,937.66 | 2019-2025 | |
| Janssen Biotech, INC. | $1,849.13 | 2019-2025 | Tremfya |
| Novartis Pharmaceuticals Corporation | $1,316.25 | 2019-2025 | |
| Sun Pharmaceutical Industries INC. | $1,234.10 | 2019-2025 | Ilumya, Winlevi |
| Leo Pharma INC. | $949.45 | 2020-2025 | Adbry |
| Pfizer INC. | $865.92 | 2019-2025 | |
| Incyte Corporation | $848.04 | 2021-2025 | Opzelura |
| Dermavant Sciences, INC. | $649.40 | 2022-2024 | Vtama |
| E.R. Squibb & Sons, L.L.C. | $598.12 | 2022-2025 | Sotyktu |
| Lilly USA, LLC | $593.62 | 2019-2025 | Taltz, Olumiant, Ebglyss |
| Galderma Laboratories, L.P. | $569.59 | 2019-2025 | Aklief, Oracea, Nemluvio |
| Ucb, INC. | $463.82 | 2020-2025 | Cimzia, Bimzelx |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $460.00 | 2019-2025 | Siliq, Jublia, Duobrii |
| Arcutis Biotherapeutics, INC. | $369.22 | 2023-2025 | Zoryve |
Show all 38 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Janet Lin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.